Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
about
Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infectionEvidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naïve MiceCritical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpoxStructure and mechanism of IFN- antagonism by an orthopoxvirus IFN- -binding proteinPoxvirus tropismPoxviruses and the evolution of host range and virulenceStudy of camelpox virus pathogenesis in athymic nude miceImmune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected miceIdentification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccinesSurviving mousepox infection requires the complement systemA method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.Interferon function is not required for recovery from a secondary poxvirus infection.EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulenceImpact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responsesProtective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.Obligatory requirement for antibody in recovery from a primary poxvirus infectionVaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungsThe ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responsesInhibition of cowpox virus and monkeypox virus infection by mitoxantrone.Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infectionInduction of natural killer cell responses by ectromelia virus controls infection.Viral modulation of NK cell immunity.Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunityLethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon responseComparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicityLoss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protectionSoft-X-ray-enhanced electrostatic precipitation for protection against inhalable allergens, ultrafine particles, and microbial infections.Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer.The orchestrated functions of innate leukocytes and T cell subsets contribute to humoral immunity, virus control, and recovery from secondary poxvirus challengeCorrelates of protective immunity in poxvirus infection: where does antibody stand?On the potential of oncolytic virotherapy for the treatment of canine cancers.T cell receptor sharing by cytotoxic T lymphocytes facilitates efficient virus control.The smallpox vaccine induces an early neutralizing IgM response.Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.NK cells and poxvirus infection.A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection.
P2860
Q27313373-18C1D856-5CD5-4395-941E-F3CB053FA4C0Q27316583-B25F1CF7-4CDE-4CFB-82E3-472774AE00D0Q27346933-D940F8EC-B94C-4BFB-A541-2E61C0B751A6Q27649793-8D000B76-04B0-4A2E-AD23-0BA70A2EB0CFQ28237434-77B53C46-B77E-4998-8126-59DA0B4ADE7DQ28658130-4696A76C-8F7B-412C-8C21-29067342C7F9Q28743156-5BE78FB6-A160-4FAD-B68D-7F98CCEF05D7Q28748570-21070298-A020-4806-8DBD-DDCD3EA48FD9Q33210436-D002F29A-6306-4DB8-9E18-34A5EFE1AE7FQ33396210-A8B5C69D-233D-4C70-8AC4-F48695B19C2DQ33429965-0B32BDCF-56EB-4257-8AA4-8793B362F42FQ33570349-684F4D8A-A8A6-4618-AF28-F3F9B0A2B4F3Q33943914-AB86E2E7-E07B-4ED1-8576-6640CE5444CDQ34047542-86231F96-8B82-42E7-8C71-11A458E47DA0Q34059488-20F906FB-4B2C-4467-AA8A-C8E1335EC949Q34716960-33C8941B-ABB0-4710-95B8-B84AC0F56F19Q34717009-F09B48B8-BB40-42ED-8CC2-7EBB65BEE699Q34991389-6D126242-5834-4F1B-9880-0456539BB466Q35261304-F29CA5CE-5483-4995-A73C-3444F03BB9AFQ35271742-016FDC8A-A699-4B50-AC5D-2C5B21BFD804Q35362732-F8B5C352-C2D4-4A6D-A758-C97D31D49117Q35738585-DE9DC932-659F-4189-A04E-D2D2492B715BQ35784998-EB9B0466-898F-4D29-A9EE-F937A185B678Q35785427-C0C4620A-531B-4DF9-9875-68547AC5A7BDQ35988761-9E3FD258-C97C-4F66-B70D-F3FA75A46D11Q36053149-14123901-16A1-4515-9E0D-CEB67C93C4B8Q36155001-441E49DC-5457-49F2-84DB-4325CB509012Q36155548-95204AF1-1C79-4C62-8F2B-69F6E5C74898Q36155569-C26D4B01-6BC2-49D2-AA92-8659FF6AAEABQ36532515-79B67F8A-6DFF-4FAE-BDB4-A83EA8FF169AQ36599163-FFB16191-397B-436F-8EAC-FDC38782ABDAQ36664277-C40E135A-FAAB-4506-A509-31F4A302AEB0Q36759794-C0A7529D-7B1A-4224-965A-4564936AC5F2Q36965655-945B372F-4150-4A0C-9862-7301A9878432Q37031925-8089D0F4-09F1-41F0-A02E-0433A0B6030CQ37329660-FF669B2D-3E9A-49A9-825C-0776168DBA73Q37456873-E81CE908-1CB4-4E1D-843A-4869CD81FF00Q37791160-C6B4E313-B8D2-47E8-B6C9-990CDA548262Q38078359-364E76C5-6F76-440E-B1B0-74030D0CE0FAQ38802297-2149974C-2CC8-4357-A127-8FFB59861C15
P2860
Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@ast
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@en
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@nl
type
label
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@ast
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@en
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@nl
prefLabel
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@ast
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@en
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@nl
P2093
P2860
P356
P1476
Polarized type 1 cytokine resp ...... enetic resistance to mousepox.
@en
P2093
Alfons J M van den Eertwegh
Eric Claassen
Geeta Chaudhri
Gunasegaran Karupiah
Jon D Laman
R Mark L Buller
Rosalind de Chazal
Vijay Panchanathan
P2860
P304
P356
10.1073/PNAS.0402949101
P407
P577
2004-06-07T00:00:00Z